全文获取类型
收费全文 | 5810841篇 |
免费 | 436354篇 |
国内免费 | 17485篇 |
专业分类
耳鼻咽喉 | 81140篇 |
儿科学 | 186919篇 |
妇产科学 | 155402篇 |
基础医学 | 853376篇 |
口腔科学 | 165430篇 |
临床医学 | 539560篇 |
内科学 | 1066796篇 |
皮肤病学 | 138336篇 |
神经病学 | 481309篇 |
特种医学 | 220505篇 |
外国民族医学 | 1384篇 |
外科学 | 861525篇 |
综合类 | 159718篇 |
现状与发展 | 25篇 |
一般理论 | 3155篇 |
预防医学 | 485692篇 |
眼科学 | 139871篇 |
药学 | 415211篇 |
28篇 | |
中国医学 | 16408篇 |
肿瘤学 | 292890篇 |
出版年
2021年 | 61158篇 |
2019年 | 68230篇 |
2018年 | 86999篇 |
2017年 | 67669篇 |
2016年 | 74718篇 |
2015年 | 86399篇 |
2014年 | 121281篇 |
2013年 | 189603篇 |
2012年 | 176660篇 |
2011年 | 189544篇 |
2010年 | 147069篇 |
2009年 | 141574篇 |
2008年 | 171048篇 |
2007年 | 184349篇 |
2006年 | 189222篇 |
2005年 | 182749篇 |
2004年 | 181784篇 |
2003年 | 170037篇 |
2002年 | 158162篇 |
2001年 | 234555篇 |
2000年 | 232964篇 |
1999年 | 205487篇 |
1998年 | 80947篇 |
1997年 | 73896篇 |
1996年 | 71620篇 |
1995年 | 67145篇 |
1994年 | 60963篇 |
1993年 | 56297篇 |
1992年 | 151922篇 |
1991年 | 145722篇 |
1990年 | 140952篇 |
1989年 | 136982篇 |
1988年 | 126295篇 |
1987年 | 123740篇 |
1986年 | 116732篇 |
1985年 | 113464篇 |
1984年 | 90214篇 |
1983年 | 78774篇 |
1982年 | 55941篇 |
1981年 | 51312篇 |
1980年 | 48023篇 |
1979年 | 79776篇 |
1978年 | 60756篇 |
1977年 | 53222篇 |
1976年 | 49500篇 |
1975年 | 51000篇 |
1974年 | 58209篇 |
1973年 | 56161篇 |
1972年 | 52687篇 |
1971年 | 48952篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
961.
Jim Siderov 《Journal of clinical oncology》2003,21(10):2044-5; author reply 2045
962.
963.
A M Carella 《Leukemia》2003,17(6):1199-1200
964.
Dr. med. Dr. jur. R. Erlinger 《Der Onkologe》2003,9(8):865-868
Ohne Zusammenfassung 相似文献
965.
Daoyan Wei Henry Q. Xiong James L. Abbruzzese Keping Xie 《Journal of gastrointestinal cancer》2003,33(1):43-60
Pancreatic cancer is a lethal disease characterized by early metastasis, local invasion, and resistance to conventional therapies. To understand its etiology and eventually make prevention of it possible and effective, appropriate carcinogenesis models will certainly help us understand the effects of environmental and genetic elements on pancreatic carcinogenesis. The development of new treatment strategies to control cancer metastasis is of immediate urgency. Fulfillment of this task relies on our knowledge of the cellular and molecular biology of pancreatic cancer metastasis and the availability of biologically and clinically relevant model systems. Many of the existing pancreatic cancer carcinogenesis and metastasis animal models are described in this review. The advantages and disadvantages of each model and their clinical implications are discussed, and special attention is focused on experimental therapeutic strategies targeting pancreatic cancer metastasis. 相似文献
966.
Burkitt’s lymphoma is a high-grade, rapidly growing B-cell neoplasm. It is recognized by its aggressive course, brief median survival, and low rates of long-term survival. The authors discuss the case of a patient who acutely presented with intraabdominal complications from a new onset of Burkitt’s lymphoma. The clinical and pathological features, staging, treatment options, and survival data are reviewed. In addition, the role of surgical intervention is carefully analyzed. 相似文献
967.
肝癌间质及癌旁病变的病理分析 总被引:2,自引:0,他引:2
目的 研究肝癌间质及癌旁病变的临床病理意义。方法 在 2 0例肝癌组织标本中取 45个癌结节 ,分别在癌结节中间、癌旁肝组织等部位取组织 4块 ,连续切片 ,显微镜下观察。结果 19个结节有完整窦内皮细胞围绕癌巢 ,其中癌结节肉眼小于3cm者 13个 ,大于 3cm者 6个。 2 6个癌结节无完整窦内皮细胞围绕癌巢 ,其中癌结节直径大于 3cm者 2 4个 ,小于 3cm者 2个。2 0例中有 13例合并肝硬化 ,17例有乙型肝炎病毒感染和HBsAg阳性。 结论 病理连续切片 ,显微镜下观察肝癌间质及癌旁病变是预测肝癌患者预后的重要病理学指标 相似文献
968.
Manuel Steiner Andishe Attarbaschi Margit K nig Helmut Gadner Oskar A. Haas Georg Mann 《Pediatric hematology and oncology》2004,22(1):11-16
Constitutional trisomy 21 is the most prominent predisposing factor to childhood leukemia, whereas the t(12;21)(p13;q22) with its molecular genetic counterpart, the TEL/AML1 fusion gene, is the most common acquired chromosomal rearrangement in childhood B-cell precursor (BCP) acute lymphoblastic leukemia (ALL). Thus, it was somewhat surprising that according to the currently available literature the incidence of TEL/AML1+ BCP ALL is extremely low in patients with Down syndrome (DS). To further investigate this issue in a population-based fashion, the authors retrospectively assessed the number of DS patients with a TEL/AML1+ ALL in two consecutive Austrian ALL multicenter trials. Accordingly, they were able to analyze 8 of 10 individuals with DS and a BCP ALL, including 2 who suffered from a TEL/AML1+ leukemia. Based on this observation we concluded that individuals with a constitutional trisomy 21 may have the similar likelihood to develop a TEL/AML1+ leukemia as BCP ALL patients without this specific predisposing factor. 相似文献
969.
Johannes Brettschneider Axel Petzold Sigurd D Süssmuth Georg B Landwehrmeyer Albert C Ludolph Jan Kassubek Hayrettin Tumani 《Movement disorders》2006,21(12):2224-2227
We aimed to evaluate the potential of the cerebrospinal fluid (CSF) axonal damage biomarker NfH(SMI35) in the laboratory-supported differential diagnosis of parkinsonian syndromes. Patients with idiopathic Parkinson's disease (PD; n = 22), multiple-system atrophy (MSA; n = 21), progressive supranuclear palsy (PSP; n = 21), corticobasal degeneration (CBD; n = 6), and age-matched controls (n = 45) were included. CSF levels of NfH(SMI35) were measured using ELISA. Levels of CSF NfH(SMI35) were elevated in PSP compared to PD and controls (P < 0.05 each). They were also significantly higher in MSA than in PD and controls (P < 0.05 each). NfH(SMI35) differentiated PD from PSP with a sensitivity of 76.5% and a specificity of 94.4%. Axonal damage as measured by CSF NfH(SMI35) is most prominent in the more rapidly progressive syndromes PSP and MSA as compared to PD or CBD. CSF NfH(SMI35) may therefore be of some value for the laboratory-supported differential diagnosis of atypical parkinsonian syndromes. 相似文献
970.
S Dvorakova E Vaclavikova A Ryska J Cap P Vlcek J Duskova D Kodetova V Holub Z Novak B Bendlova 《Experimental and clinical endocrinology & diabetes》2006,114(4):192-196
Medullary thyroid carcinoma (MTC) is a rare form of thyroid cancer representing about 10% of all thyroid malignancies. It occurs mostly as a sporadic tumor or in association with autosomal dominant inherited cancer syndromes--multiple endocrine neoplasia (MEN) types 2A and 2B and familial MTC. Germline mutations in exons 8, 10, 11, 13, 14, 15 and 16 of the RET proto-oncogene are found in most of the familial cases. There are only a few published data reporting multiple germline mutations in the RET proto-oncogene. We have detected double germline mutations in 2 different exons on the same RET allele in two MEN 2 families. In the MEN 2A family, double germline mutation in exons 10 (Cys620Phe) and 13 (Tyr791Phe) was detected. In the MEN 2B family, beside the classical germline mutation in exon 16 (Met918Thr) a second germline mutation in exon 13 (Tyr791Phe) was found. This study revealed that MEN 2 syndromes can also be caused by double germline mutations in the RET proto-oncogene and these families can be added to small worldwide cohort of families with multiple germline mutations. 相似文献